by acaballero | Aug 8, 2024 | Industry insights
Written by Sneha Bhadti, David Pritchett, & Susan O’Connell The implementation of the European Union (EU) joint clinical assessment (JCA) process is fast approaching. In January 2025, the JCA will be rolled out for new oncology and orphan medications....
by Rachel Montague | Jul 15, 2024 | Industry insights
Written by Susan O’Connell, Louise Crathorne, & Sneha Bhadti In the realm of healthcare innovation, the European Union (EU) is paving the way with the Joint Clinical Assessment (JCA) process In this background article, Source aims to highlight some of the...
by Rachel Montague | Jul 1, 2024 | Industry insights
Written by Ciara Thomas, Vicky Crowe, & David Pritchett Introduction To achieve optimal patient outcomes, systematic literature reviews (SLRs) must synthesise high quality, contemporary evidence to inform health policy and practice (1, 2). SLRs can be time...
by acaballero | Apr 9, 2024 | Industry insights
Written by Hannah Shapiro Quality assessment in single-arm trials Quality assessment is a vital aspect of conducting a thorough systematic literature review (SLR), as the validity of the conclusions of the review depends on the reliability of the included...
by acaballero | Mar 25, 2024 | Industry insights
Written by Kiera Lander, Assistant Project Manager The National Institute for Health and Care Excellence (NICE) has long been at the forefront of health technology assessment (HTA), ensuring that patients have access to innovative, efficacious medicines....
by acaballero | Mar 18, 2024 | Industry insights
Written by Brian O’Toole, HTA Writing Lead Last year I changed jobs. It was a major life decision that took time to make as it meant leaving the comfort and familiarity of academia for the hustle and bustle of a market access consultancy. For the past...
